A Study on Drug Utilization evaluation of Anti cancer drugs Used in Oncology department Under National health Scheme of Ayushman bharath Arogya Karnataka Ina Tertiary Care Teaching hospital
Main Article Content
Abstract
DUE is an ongoing systematic process that promotes rational use of drugs, it is an integral part of patient care and could also be used to assess the quality of services delivered for patients in different medicare system, including oncology. The study's major goal is to improve patient knowledge in all areas, which will help to improve current health care as well as find the various forms of cancer, most frequently prescribed drugs, rational use of cytotoxic medication and prescription indicator(s) in a tertiary care teaching hospital.
References
Sachdeva MP.
Drug utilization studies: scope and future perspectives.
Available from: https://www.semanticscholar.org/paper/4dd296c69dc99a8ab717aec03eedd17291d16e3
(cited 2021 Jul 27).
Balkhi B, Alqahtani S, Altayyar W, et al.
Drug utilization and expenditure of anticancer drugs for breast cancer.
Saudi Pharm J. 2020;28(6):669–674.
Arogya Karnataka Health Card 2021 [Internet].
Available from: Mera.pmjay.gov.in (cited 2021 Sep 29).
Dhaka R, Verma R, Agrawal G, et al.
Ayushman Bharat Yojana: a memorable health initiative for Indians.
Int J Community Med Public Health. 2018;5(8):3152.
NCCN Clinical Practice Guidelines in Oncology [Internet].
Available from: https://www.nccn.org/professionals/
(cited 2021 Sep 29).
American Society of Clinical Oncology [Internet].
Available from: https://www.asco.org
(cited 2021 Sep 29).
National List of Essential Medicines [Internet].
Available from: https://vikaspedia.in/health/nrhm/national-health-policies/national-list-of-essential-medicines
(cited 2021 Sep 29).
Dave D, Pillai A, Shah D, et al.
An analysis of utilization pattern of anticancer drugs in diagnosed cases of carcinoma in a tertiary care teaching hospital.
Available from: https://www.semanticscholar.org/paper/f315b85ddc74d8440737ceaba52684b5884803a
(cited 2021 Nov 28).
Kamlekar S, Agarwal A, Aasha, et al.
Evaluation of drug utilization of anticancer drugs in an oncology department of a tertiary care teaching hospital in southern Rajasthan.
Natl J Physiol Pharm Pharmacol. 2019;0(0):1.
Khan G, Thapa R, Adhikari D, Rajbhandari M, Dwa P, Shrestha S.
Evaluation of cancer prevalence and cytotoxic medication prescribing in central region of Nepal.
Kathmandu Univ J Sci Eng Technol. 2013;9(1):189–199.
Manichavasagam M, et al.
Prescribing pattern of anticancer drugs in a medical oncology department of a tertiary care teaching hospital.
Ann Med Health Sci Res. 2017;7:1–3.
Mugada V, Paruchuri A, Munagala M.
Drug utilization evaluation of anticancer drugs in a tertiary care teaching hospital: a descriptive observational study.
J Appl Pharm Sci. 2016;6(10):098–101.
Ramalakshmi S, Ramesh A, Sahini A, Babu KS, Kousalya K, Saranya P.
A study on prescribing trends of supportive care drugs used in cancer chemotherapy in a tertiary care teaching hospital.
Indian J of Oncology Pharmacy Practice. 2013;6:36–39.
Wilking N, Hofmarcher T, Wilking U, et al.
Drug utilization research in the area of cancer drugs.
In: Drug Utilization Research. Chichester, UK: John Wiley & Sons; 2016:315–327.
Mathew M, Mateti UV, Saj N, et al.
Drug utilization evaluation of anticancer drugs in a charitable hospital.
Indian J Med Paediatr Oncol. 2019;40(1):105–110.
Bepari A, Sakre N, Rahman I, Niazi SK, Dervesh AM.
The assessment of drug utilization study of anticancer drugs using WHO prescribing indicators in a government tertiary care hospital of the Hyderabad Karnataka region of India.
Open Access Maced J Med Sci. 2019;7(7):1203–1208.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.